Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05433272 |
|
Recruitment Status :
Not yet recruiting
First Posted : June 27, 2022
Last Update Posted : January 12, 2023
|
Sponsor:
Sinovac Biotech (Colombia) S.A.S.
Collaborator:
Sinovac Life Sciences Co., Ltd.
Information provided by (Responsible Party):
Sinovac Biotech Co., Ltd ( Sinovac Biotech (Colombia) S.A.S. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | September 10, 2023 |
| Estimated Study Completion Date : | September 10, 2023 |